Sarepta Therapeutics Inc (SRPT)
Quick ratio
| Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | ||
|---|---|---|---|---|---|---|
| Cash | US$ in thousands | 428,430 | 966,777 | 2,115,870 | 1,502,650 | 835,080 |
| Short-term investments | US$ in thousands | 1,247,820 | 1,022,600 | 0 | 435,923 | 289,668 |
| Receivables | US$ in thousands | 403,058 | 217,939 | 152,990 | 101,340 | 90,879 |
| Total current liabilities | US$ in thousands | 653,659 | 619,604 | 452,733 | 416,026 | 264,767 |
| Quick ratio | 3.18 | 3.56 | 5.01 | 4.90 | 4.59 |
December 31, 2023 calculation
Quick ratio = (Cash + Short-term investments + Receivables) ÷ Total current liabilities
= ($428,430K
+ $1,247,820K
+ $403,058K)
÷ $653,659K
= 3.18
The quick ratio of Sarepta Therapeutics Inc has shown a declining trend over the past five years from 4.59 in 2019 to 3.18 in 2023. This ratio indicates the company's ability to meet its short-term financial obligations with its most liquid assets excluding inventory.
A quick ratio above 1 suggests that the company is sufficiently capable of covering its current liabilities with its quick assets. Sarepta's quick ratio has consistently exceeded this threshold over the years, indicating a strong liquidity position.
However, the gradual decline in the quick ratio may signal a decrease in the company's ability to pay off its short-term obligations with immediate resources. It is essential for investors and stakeholders to monitor this trend closely to ensure the company's liquidity remains robust and sustainable.
Peer comparison
Dec 31, 2023